Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02966756
Recruitment Status : Recruiting
First Posted : November 17, 2016
Last Update Posted : January 24, 2022
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 31, 2024
Estimated Study Completion Date : November 15, 2024